Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dr. Reddy’s Signs MoU With State of Louisiana
Dr. Reddy’s has signed a Memorandum of Understanding (MoU) with the state of Louisiana on 7th December 2009, to expand its Shreveport operations with incentives and support from
Dr. Reddy’s has signed a Memorandum of Understanding (MoU) with the state of Louisiana on 7th December 2009, to expand its Shreveport operations with incentives and support from
Covance has opened new clinical development offices in Seoul, South Korea and Mumbai, India. The company has also expanded offices in Tokyo, Japan and Hong Kong, China, to
Rib-X Pharmaceuticals (Rib-X) has entered into a collaborative research agreement with Massachusetts General Hospital (MGH). Under the science plan for the collaboration, David Hooper of MGH will evaluate
SRI International has received the US patent 7592021 for a new bioadhesive drug delivery system that enables enhanced release of drugs through the human body’s mucous membranes. The
Almac Discovery (Almac) has initiated Phase I clinical trial of the intranasal Granisetron product. The product, which uses Archimedes’ proprietary ChiSys delivery technology, is being developed as a
Femta Pharmaceuticals (Femta) and Lonza have entered into a manufacturing services agreement to facilitate the development and cGMP manufacturing of FM101. FM101 is a monoclonal antibody in late
Advaxis is going to collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, phase II clinical trial
Arkray has re-introduced the CLIA waived DiaScreen 50 Urine Chemistry Analyzer. The company’s DiaScreen 50 enables easy in-office urine testing. It provides instrument read results that eliminate color
Jazz Pharmaceuticals (Jazz) has submitted a New Drug Application (NDA) to the FDA for JZP-6 (sodium oxybate oral solution), for the treatment of fibromyalgia. Sodium oxybate is the
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, has expanded its phase II clinical study of a vaccine against Clostridium difficile infection (CDI) into the US. The trial,